scispace - formally typeset
Journal ArticleDOI

4. Modelling Survival Data in Medical Research

About
This article is published in Journal of The Royal Statistical Society Series A-statistics in Society.The article was published on 1995-01-01. It has received 1092 citations till now. The article focuses on the topics: Medical research.

read more

Citations
More filters
Journal ArticleDOI

combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines

TL;DR: The proposed simple guidelines for combining estimates after MI may lead to a wider and more appropriate use of MI in future prognostic modelling studies.
Journal ArticleDOI

Blood pressure and cardiovascular disease in the Asia Pacific region.

TL;DR: Blood pressure was at least as strongly associated with cardiovascular events in Asian populations compared to Australasian populations and considerable potential benefit of blood pressure lowering down to levels of at least 115 mmHg systolic blood pressure is seen.
Journal ArticleDOI

Variations in Lung Cancer Risk Among Smokers

TL;DR: The risk of lung cancer varies widely among smokers, and accurate risk prediction may help individuals who are contemplating voluntary screening to balance the potential benefits and risks.
Journal ArticleDOI

Association Among SF36 Quality of Life Measures and Nutrition, Hospitalization, and Mortality in Hemodialysis

TL;DR: In patients on MHD the SF36 appears to have significant associations with measures of nutritional status, anemia, and clinical outcomes, including prospective hospitalization and mortality, even though obesity, unlike undernutrition, is not generally an indicator of poor outcome in MHD.
References
More filters
Journal ArticleDOI

Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

TL;DR: Hyperphosphatemia and hyperparathyroidism were significantly associated with all-cause, cardiovascular, and fracture-related hospitalization, and the population attributable risk percentage for disorders of mineral metabolism was 17.5%, owing largely to the high prevalence of hyperph phosphatemia.
Journal ArticleDOI

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

TL;DR: Sunitinib demonstrates longer overall survival compared with IFN-alpha plus improvement in response and progression-free survival in the first-line treatment of patients with metastatic RCC, highlighting an improved prognosis in patients with RCC in the era of targeted therapy.
Journal ArticleDOI

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

TL;DR: Five prognostic factors for predicting survival were identified and used to categorize patients with metastatic RCC into three risk groups, for which the median survival times were separated by 6 months or more.